SPDR S&P Biotech ETF (NYSEARCA:XBI) Sees Unusually-High Trading Volume – Should You Buy?

SPDR S&P Biotech ETF (NYSEARCA:XBI) saw an uptick in trading volume on Friday . 8,628,745 shares were traded during trading, a decline of 8% from the previous session’s volume of 9,365,712 shares.The stock last traded at $93.35 and had previously closed at $96.96.

SPDR S&P Biotech ETF Trading Down 5.3 %

The company’s 50 day moving average price is $98.95 and its 200 day moving average price is $96.11. The company has a market cap of $7.00 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Tidemark LLC raised its position in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the last quarter. ORG Partners LLC purchased a new stake in SPDR S&P Biotech ETF during the second quarter worth approximately $40,000. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $40,000. ORG Wealth Partners LLC purchased a new position in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $44,000. Finally, Howe & Rusling Inc. acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter worth $49,000.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.